Equities

Genincode PLC

GENI:LSE

Genincode PLC

Health CareMedical Equipment and Services
  • Price (GBX)5.50
  • Today's Change-0.125 / -2.22%
  • Shares traded451.50k
  • 1 Year change-46.34%
  • Beta--
Data delayed at least 20 minutes, as of Sep 27 2024 14:52 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Genincode PLC had net income fall 26.21% from a loss of 5.56m to a larger loss of 7.02m despite revenues that grew 51.05% from 1.43m to 2.16m over the same period.
Gross margin47.31%
Net profit margin-324.81%
Operating margin-331.06%
Return on assets-87.79%
Return on equity-152.70%
Return on investment-124.10%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Genincode PLC fell by 7.25m. However, Cash Flow from Investing totalled 136.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 7.29m for operations while cash used for financing totalled 94.00k.
Cash flow per share-0.0696
Price/Cash flow per share--
Book value per share0.0135
Tangible book value per share0.0105
More ▼

Balance sheet in GBPView more

Genincode PLC has a Debt to Total Capital ratio of 18.83%, a higher figure than the previous year's 3.61%.
Current ratio1.28
Quick ratio1.24
Total debt/total equity0.232
Total debt/total capital0.1883
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.